The global AI in precision medicine market is anticipated to grow at a CAGR of 19.2% during the forecast period. Several methods use a machine learning (ML) model to categorize genes as tumor suppressors, oncogenes, or neutral genes. Both known oncogenes and tumor-suppressor genes, such as TP53 and PIK3CA, were successfully predicted by using an AI-based precision medicine techniques. For instance,

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ai-in-precision-medicine-market

In July 2022, IIT Madras, the Indian Institute of Technology Researchers developed the 'PIVOT' technology, utilizing an AI platform to forecast an individual's cancer-causing genes. In the end, this instrument will support the development of personalized cancer treatment regimens. "PIVOT," developed by IIT Madras researchers, aims to pinpoint the genes that are most likely to influence a person's risk of developing cancer.
In June 2023, The new PrimateAI-3D AI tool from Illumina Inc., a DNA sequencing and array-based technology, correctly predicts disease-causing genetic alterations in patients with previously unheard-of accuracy. Understanding and modifying the genetic code will soon be possible with the development of new tools like high-performance computers for genomic analytics and artificial intelligence that can foresee three-dimensional protein models.
In May 2023, Google Cloud launched two artificial intelligence-powered technologies that are designed to accelerate drug discovery including the multi-omics suite and the target and lead identification suite. Using the target and lead identification suite, researchers may forecast protein structure and ascertain how amino acids work. A clinical decision support tool, the solution enhances AI-driven precision psychiatry and is expected to improve care for millions of patients globally.
In October 2022, An AI-driven precision psychiatry solution that predicts treatment effectiveness for depression will be available to doctors through a partnership between Taliaz, an Israeli digital health company dedicated to treating mental health concerns, and Cerba, the specialized clinical pathology reference.

Global Artificial Intelligence (AI) in Precision Medicine Market Report Segment

By Component

Hardware
Software and Services

By Treatment

Oncology
Neurology
Cardiology
Respiratory

By Application

Drug Discovery & Repurposing
Clinical Research Trial
Personalized Medicine

A full report of Artificial Intelligence (AI) in Precision Medicine Market available @  https://www.omrglobal.com/industry-reports/ai-in-precision-medicine-market

Company Profiles

Alphabet Inc.
AstraZeneca
Atomwise Inc.
Berg LLC
BioXcel Therapeutics Inc.
Enlitic Inc.
GE Healthcare
IBM Corp.
Insilico Medicine
Modernizing Medicine Inc.
Novo Nordisk A/S

Reasons to Buying From us –

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404

Company Name: Orion Market Research

Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f